| BHYAX | SPHIX | BHYAX / SPHIX | |
| Total Expense Ratio | 0.92 | 0.69 | 133% |
| Annual Report Gross Expense Ratio | 0.93 | 0.69 | 135% |
| Fund Existence | 28 years | 36 years | - |
| Gain YTD | 2.243 | 3.369 | 67% |
| Front Load | 4% | N/A | - |
| Min. Initial Investment | 1000 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 27.7B | 3B | 922% |
| Annual Yield % from dividends | 6.32 | 6.52 | 97% |
| Returns for 1 year | 5.01 | 7.11 | 70% |
| Returns for 3 years | 28.13 | 32.63 | 86% |
| Returns for 5 years | 22.46 | 22.60 | 99% |
| Returns for 10 years | 65.02 | 61.46 | 106% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| FTXH | 42.76 | 0.54 | +1.27% |
| First Trust Nasdaq Pharmaceuticals ETF | |||
| TPIF | 39.15 | 0.27 | +0.69% |
| Timothy Plan International ETF | |||
| QRMI | 15.12 | 0.03 | +0.23% |
| Global X NASDAQ 100® Risk Mngd Inc ETF | |||
| EVHY | 52.33 | 0.12 | +0.22% |
| Eaton Vance High Yield ETF | |||
| LMNX | 18.59 | N/A | N/A |
| Defiance Daily Target 2X Long LMND ETF | |||